scispace - formally typeset
Open AccessJournal ArticleDOI

D-cysteine is an endogenous regulator of neural progenitor cell dynamics in the mammalian brain.

TLDR
Using chiral high-performance liquid chromatography and a stereospecific luciferase assay, this paper identified endogenous d-cysteine in the mammalian brain and implicate it as a physiologic regulator of NPC homeostasis in the developing brain.
Abstract
d-amino acids are increasingly recognized as important signaling molecules in the mammalian central nervous system. However, the d-stereoisomer of the amino acid with the fastest spontaneous racemization ratein vitro in vitro, cysteine, has not been examined in mammals. Using chiral high-performance liquid chromatography and a stereospecific luciferase assay, we identify endogenous d-cysteine in the mammalian brain. We identify serine racemase (SR), which generates the N-methyl-d-aspartate (NMDA) glutamate receptor coagonist d-serine, as a candidate biosynthetic enzyme for d-cysteine. d-cysteine is enriched more than 20-fold in the embryonic mouse brain compared with the adult brain. d-cysteine reduces the proliferation of cultured mouse embryonic neural progenitor cells (NPCs) by ∼50%, effects not shared with d-serine or l-cysteine. The antiproliferative effect of d-cysteine is mediated by the transcription factors FoxO1 and FoxO3a. The selective influence of d-cysteine on NPC proliferation is reflected in overgrowth and aberrant lamination of the cerebral cortex in neonatal SR knockout mice. Finally, we perform an unbiased screen for d-cysteine-binding proteins in NPCs by immunoprecipitation with a d-cysteine-specific antibody followed by mass spectrometry. This approach identifies myristoylated alanine-rich C-kinase substrate (MARCKS) as a putative d-cysteine-binding protein. Together, these results establish endogenous mammalian d-cysteine and implicate it as a physiologic regulator of NPC homeostasis in the developing brain.

read more

Citations
More filters
Journal ArticleDOI

Mammalian D‐cysteine: A novel regulator of neural progenitor cell proliferation

Robin Roychaudhuri, +1 more
- 28 Apr 2022 - 
TL;DR: It is hypothesized that in the developing brain endogenous D‐cysteine is as a physiologic regulator of NPC proliferation by inhibiting AKT signaling mediated by Foxo1 and Foxo3a.
Journal ArticleDOI

D-Amino Acids as a Biomarker in Schizophrenia

TL;DR: An outline of the roles of D-amino acids in brain health and neuropsychiatric disorders with a focus on schizophrenia is provided, which may shed light on some of the superior diagnoses and/or treatments of schizophrenia.
Journal ArticleDOI

Promising Application of D-Amino Acids toward Clinical Therapy

TL;DR: In this article , the potential of D-amino acids as therapeutic agents for treating neurological disease or tissue/organ injury, ameliorating reproduction function, preventing biofilm infection, and inhibiting cancer cell growth.
Journal ArticleDOI

A Novel Stereospecific Bioluminescent Assay for Detection of Endogenous d-Cysteine.

TL;DR: In this paper , a stereospecific, bioluminescent assay was used to identify endogenous d-cysteine in substantial amounts in the eye, brain, and pancreas of mice.
Journal ArticleDOI

D-Cysteine Ethyl Ester Reverses the Deleterious Effects of Morphine on Breathing and Arterial Blood–Gas Chemistry in Freely-Moving Rats

TL;DR: D-CYSee and related thiol esters may have clinical potential for the reversal of the adverse effects of opioids on breathing and gas exchange, while largely sparing antinociception and sedation.
References
More filters
Journal ArticleDOI

Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor

TL;DR: It is demonstrated that Akt also regulates the activity of FKHRL1, a member of the Forkhead family of transcription factors, which triggers apoptosis most likely by inducing the expression of genes that are critical for cell death, such as the Fas ligand gene.
Journal ArticleDOI

AKT/PKB signaling: navigating downstream.

TL;DR: Those Akt substrates that are most likely to contribute to the diverse cellular roles of Akt, which include cell survival, growth, proliferation, angiogenesis, metabolism, and migration are discussed.
Journal ArticleDOI

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.

TL;DR: It is shown that agents which prevent the activation of both MAPKAP kinase-1 and p70S6k by insulin in vivo do not block the phosphorylation and inhibition of GSK3, and it is demonstrated that PKB is the product of the proto-oncogene protein kinase B (PKB, also known as Akt/RAC).
Journal ArticleDOI

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

TL;DR: It is shown that TSC1–TSC2 inhibits the p70 ribosomal protein S6 kinase 1 and activates the eukaryotic initiation factor 4E binding protein 1 (4E-BP1, an inhibitor of translational initiation) and these functions are mediated by inhibition of the mammalian target of rapamycin (mTOR).
Journal ArticleDOI

Mechanism of activation of protein kinase B by insulin and IGF-1.

TL;DR: In this paper, the activation of PKBalpha was accompanied by its phosphorylation at Thr308 and Ser473 and, like activation, likeactivation was prevented by the phosphatidylinositol 3-kinase inhibitor wortmannin.
Related Papers (5)